The Valley Desk

NCT01844986 · Interventional trial

Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.

Overall registry status Active not recruiting

Phase 3

Conditions Advanced Ovarian Cancer, BRCA Mutation, Complete Response, FIGO Stage III-IV, First Line Platinum Chemotherapy, Newly Diagnosed, Partial Response

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov